The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children - PubMed (original) (raw)
Clinical Trial
doi: 10.1086/315639. Epub 2000 Jun 27.
R Chandwani, M E Sheehy, J Dobroszycki, G Fennelly, A Wiznia, J Radding, M Rigaud, H Pollack, W Borkowsky, M Rosenberg, D F Nixon
Affiliations
- PMID: 10882585
- DOI: 10.1086/315639
Clinical Trial
The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children
H M Spiegel et al. J Infect Dis. 2000 Jul.
Abstract
This cross-sectional study investigated the effect of early highly active antiretroviral therapy (HAART) on human immunodeficiency virus (HIV) type 1-specific CD8 T cell responses in children. HIV-1-specific CD8 T cell responses were quantified using an enzyme-linked immunospot assay to measure interferon-gamma-secreting cells. HIV-1-infected children were classified by time of HAART initiation prior to age 1 year or after age 2 years as early (n=24) or late (n=28) treated. The magnitude and breadth of the HIV-1-specific CD8 T cell response was significantly lower in children receiving early compared with late HAART treatment (P=.0007 and.0001, respectively). However, total CD8 T cell responses in the early HAART treatment group did not differ significantly from those of age-matched non-HAART-treated controls (n=30). Thus, the reduced magnitude and breadth of the HIV-1-specific CD8 T cell response in early HAART-treated children is due to their younger age.
Similar articles
- The frequency of HIV-specific interferon- gamma -producing CD8 T cells is associated with both age and level of antigenic stimulation in HIV-1-infected children.
Buseyne F, Scott-Algara D, Bellal N, Burgard M, Rouzioux C, Blanche S, Riviere Y. Buseyne F, et al. J Infect Dis. 2005 Nov 15;192(10):1781-6. doi: 10.1086/497152. Epub 2005 Oct 7. J Infect Dis. 2005. PMID: 16235177 Clinical Trial. - CD38 expression in CD8+ T cells predicts virological failure in HIV type 1-infected children receiving antiretroviral therapy.
Resino S, Bellón JM, Gurbindo MD, Muñoz-Fernández MA. Resino S, et al. Clin Infect Dis. 2004 Feb 1;38(3):412-7. doi: 10.1086/380793. Epub 2004 Jan 13. Clin Infect Dis. 2004. PMID: 14727214 - HIV infection and aging.
Blanco JR, Caro AM, Pérez-Cachafeiro S, Gutiérrez F, Iribarren JA, González-García J, Ferrando-Martínez S, Navarro G, Moreno S. Blanco JR, et al. AIDS Rev. 2010 Oct-Dec;12(4):218-30. AIDS Rev. 2010. PMID: 21179186 Review. - HIV-related CD8+ cutaneous pseudolymphoma: efficacy of methotrexate.
Ingen-Housz-Oro S, Sbidian E, Ortonne N, Penso-Assathiany D, Chambrin V, Bagot M, Bachelez H, Wolkenstein P, Chosidow O. Ingen-Housz-Oro S, et al. Dermatology. 2013;226(1):15-8. doi: 10.1159/000346242. Epub 2013 Jan 22. Dermatology. 2013. PMID: 23343593 Review.
Cited by
- Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals.
Kawana-Tachikawa A, Llibre JM, Bravo I, Escrig R, Mothe B, Puig J, Puertas MC, Martinez-Picado J, Blanco J, Manzardo C, Miro JM, Iwamoto A, Pozniak AL, Gatell JM, Clotet B, Brander C; MARAVIBOOST Investigators. Kawana-Tachikawa A, et al. PLoS One. 2014 Jan 27;9(1):e87334. doi: 10.1371/journal.pone.0087334. eCollection 2014. PLoS One. 2014. PMID: 24475275 Free PMC article. Clinical Trial. - Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers.
Shalekoff S, Meddows-Taylor S, Gray GE, Sherman GG, Coovadia AH, Kuhn L, Tiemessen CT. Shalekoff S, et al. AIDS. 2009 Apr 27;23(7):789-98. doi: 10.1097/QAD.0b013e328329c784. AIDS. 2009. PMID: 19293686 Free PMC article. - Pathogenesis of HIV in the gastrointestinal tract.
Dandekar S. Dandekar S. Curr HIV/AIDS Rep. 2007 Feb;4(1):10-5. doi: 10.1007/s11904-007-0002-0. Curr HIV/AIDS Rep. 2007. PMID: 17338855 Review. - Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal.
Legrand FA, Nixon DF, Loo CP, Ono E, Chapman JM, Miyamoto M, Diaz RS, Santos AM, Succi RC, Abadi J, Rosenberg MG, de Moraes-Pinto MI, Kallas EG. Legrand FA, et al. PLoS One. 2006 Dec 20;1(1):e102. doi: 10.1371/journal.pone.0000102. PLoS One. 2006. PMID: 17183635 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials